Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Oct;36(5):780-784.
doi: 10.1002/jca.21915. Epub 2021 Jun 1.

The first pediatric case of hemophagocytic lymphohistiocytosis secondary to Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange accompanying ribavirin and intravenous immunoglobulin

Zeynep Gokce Gayretli Aydin  1 , Osman Yesilbas  2 , Gokce Pinar Reis  3 , Burcu Guven  4
Affiliations
Case Reports

The first pediatric case of hemophagocytic lymphohistiocytosis secondary to Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange accompanying ribavirin and intravenous immunoglobulin

Zeynep Gokce Gayretli Aydin et al. J Clin Apher. 2021 Oct.

Abstract

Although Crimean-Congo hemorrhagic fever (CCHF) is mild and self-limited in children, some patients may develop excessive bleeding, massive liver necrosis, and multiple organ failure associated with secondary hemophagocytic lymphohistiocytosis (HLH) induced by cytokine storm. Treatment of CCHF is mainly symptomatic and supportive. The efficacy of ribavirin, which is the only antiviral drug in the treatment of CCHF, remains controversial. Although therapeutic plasma exchange (TPE) has been shown to beneficial in small case series with primary and secondary HLH, there is no pediatric patient with HLH secondary to CCHF treated with TPE in the literature. In this report, we describe the first pediatric patient who was successfully recovered from HLH secondary to CCHF with ribavirin, intravenous immunoglobulin, and TPE.

Keywords: Crimean-Congo hemorrhagic fever; hemophagocytic lymphohistiocytosis; pediatric; ribavirin; therapeutic plasma exchange.

PubMed Disclaimer

References

REFERENCES

    1. Tezer H, Sucakli IA, Sayli TR, et al. Crimean-Congo hemorrhagic fever in children. J Clin Virol. 2010;48(3):184-186.
    1. Turkish Ministry of Health. Saglik Bakanligi Kırım Kongo Kanamalı Atesi. 2021. https://hsgm.saglik.gov.tr/tr/zoonotikvektorel-kkka/zoonotikvektorel-kkk.... Accessed May 6, 2021
    1. Tuygun N, Tanir G, Caglayik DY, Uyar Y, Korukluoglu G, Cenesiz F. Pediatric cases of Crimean-Congo hemorrhagic fever in Turkey. Pediatr Int. 2012;54(3):402-406.
    1. Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6(4):203-214. https://doi.org/10.1016/S1473-3099(06)70435-2.
    1. Tasdelen Fisgin N, Fisgin T, Tanyel E, et al. Crimean-Congo hemorrhagic fever: five patients with hemophagocytic syndrome. Am J Hematol. 2008;83(1):73-76.

Publication types

MeSH terms

LinkOut - more resources